Perhpas you've seen the recent TV ad ("Ancestors") for Allergan's Kybella, a new drug approved for the treatment of double chins (read "Pfizer May Own Your Penis, But Allergan, Maker of Botox & Kybella, Owns Your Face"). The ad claims that double chins may be inherited. You can view it on iSpot.tv here.
To prove the efficacy of Kybella, several screens are devoted to showing BEFORE and AFTER photos as in the following example:
You clearly can see from these "unretouched photos" of an "Actual KYBELLA patient" that the double chin is gone.
Yesterday, Pfizer, America's largest drug company, announced plans to buy Allergan, the maker of Botox, for $160 billion. The gem in the deal: Allergan's Dublin, Ireland-based headquarters, which means that despite running the bulk ...
Botox maker Allergan said Wednesday that it had agreed to buy Westlake Village-based Kythera Biopharmaceuticals Inc. for $2.1 billion in cash and stock.
The maker of Botox is eyeing your chin. Well, chins really. Allergen is shelling out $2.1 billion for Kythera Biopharmaceuticals, which recently received a green light from the FDA for Kybella, an injection that eliminates fat cel...
The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins recently approved for use in the United States.